DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Menu-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-Modeling) | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | Diaxonhit | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | MABlife | Magnisense | Mapreg | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | NovAliX | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theradiag | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* NEORPHYS *


 

2005 - Méditerranée
Nîmes
www.neorphys.com

 

Discovery, Drugs
Key words: Nausea-free acute pain, Morphine derivatives, Opioids, Analgesics
Mission: to develop a new family of opioid analgesic drug candidates with low side effects
Clients: Pharmaceutical industry (own development up to phase IIb)
vmerchez@neorphys.com

Age: 11 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Lahana (Roger) [co-founder, born 1954, ex-Syntem]
Sc.Dir.-CSO:
Oper.Dir.-COO: Larbouret (Karine) [co-founder, ex-Syntem]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): Soridec, Inserm-Transfert, CEA Valorisation, Fa Diese 2, Seillans, plus independent business angels

Turnover (M€) : 0.017 (2007), 0.001 (2006)
Total funding (M€) : 2.3
Last funding (M€) : 1.2
Focus : Multiple
Position : Preclin
Company confirm : 6-May-2011

 

History
DATEMILESTONETYPETIME
2009 .08 1st round-financing : 1.2 M€, by Soridec, CEA Valorisation, Fa Diese 2, Seillans and a number of independent business angels RFINA [3 years]
2007 .03 Seed financing : 0.3 M€, by Soridec and Inserm-Transfert Initiative (extended to 1.05 M€ in total, mid 2008, with CEA Valorisation as additional investor) SFIN [1 year]
2006 .07 Financing (no interest loan) : 0.25 M€, by OSEO Innovation and Crealia DEBT [0 year]
2005 .09 Company founded by Roger Lahana and Karine Larbouret ORGF [0 year]

Actualisation / Updating: 6-May-2011

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2017. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende